Literature DB >> 22655796

High-mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma-interaction-dependent and -independent mechanisms.

Li-Li Wang1, Qing-Hui Meng, Yang Jiao, Jia-Ying Xu, Chun-Min Ge, Ju-Ying Zhou, Eliot M Rosen, Hai-Chao Wang, Sai-Jun Fan.   

Abstract

Our previous studies have shown that high-mobility group box 1 (HMGB1) could physically associate with the retinoblastoma (RB) protein via an LXCXE (leucine-X-cysteine-X-glutamic; X=any amino acid) motif. An identical LXCXE motif is present in the HMGB1-3 protein sequences, whereas a near-consensus LXCXD (leucine-X-cysteine-X-asparagine; X=any amino acid) motif is found in the HMGB4 protein. In this study, we have demonstrated that like HMGB1, HMGB2-3 also associated with the RB in vitro and in vivo, as evidenced by glutathione-s-transferase capture and immunoprecipitation-Western blot assays. A point mutation of the LXCXE or LXCXD motif led to disruption of RB:HMGB1-4 interactions. Enforced expression of HMGB1-3 or HMGB4 by adenoviral-vector-mediated gene transfer resulted in significant inhibition of breast cancer cell proliferation through an LXCXE- or LXCXD-dependent mechanism and an increased radiosensitivity through an LXCXE- or LXCXD-independent mechanism. These results suggest an important role of the LXCXE/D motif in RB:HMGB1-4 association and modulation of cancer cell growth, but not radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22655796      PMCID: PMC3375072          DOI: 10.1089/cbr.2012.1199

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  26 in total

1.  Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

3.  Non-histone chromosomal proteins HMG1 and 2 enhance ligation reaction of DNA double-strand breaks.

Authors:  S Nagaki; M Yamamoto; Y Yumoto; H Shirakawa; M Yoshida; H Teraoka
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

4.  Solution structure of a DNA-binding domain from HMG1.

Authors:  C M Read; P D Cary; C Crane-Robinson; P C Driscoll; D G Norman
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

5.  Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding.

Authors:  S Fan; R Yuan ; Y X Ma; J Xiong; Q Meng; M Erdos; J N Zhao; I D Goldberg; R G Pestell; E M Rosen
Journal:  Oncogene       Date:  2001-08-09       Impact factor: 9.867

Review 6.  The retinoblastoma tumour suppressor in development and cancer.

Authors:  Marie Classon; Ed Harlow
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

7.  Growth suppression and radiosensitivity increase by HMGB1 in breast cancer.

Authors:  Yang Jiao; Hai-chao Wang; Sai-jun Fan
Journal:  Acta Pharmacol Sin       Date:  2007-12       Impact factor: 6.150

8.  HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.

Authors:  J C Huang; D B Zamble; J T Reardon; S J Lippard; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Evidence for involvement of HMGB1 protein in human DNA mismatch repair.

Authors:  Fenghua Yuan; Liya Gu; Shuangli Guo; Chunmei Wang; Guo-Min Li
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

Review 10.  Masquerader: high mobility group box-1 and cancer.

Authors:  Jessica E Ellerman; Charles K Brown; Michael de Vera; Herbert J Zeh; Timothy Billiar; Anna Rubartelli; Michael T Lotze
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

View more
  15 in total

Review 1.  The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance.

Authors:  Bin Wen; Ying-Ting Wei; Kui Zhao
Journal:  Mol Cell Biochem       Date:  2021-01-11       Impact factor: 3.396

2.  High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance.

Authors:  Zhe Bao Wu; Lin Cai; Shao Jian Lin; Zhen Kun Xiong; Jiang Long Lu; Ying Mao; Yu Yao; Liang Fu Zhou
Journal:  Neuro Oncol       Date:  2013-07-04       Impact factor: 12.300

Review 3.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

4.  High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.

Authors:  Young-Joo Shin; Mi-Sook Kim; Moon-Sun Kim; Joonseok Lee; Miae Kang; Jae-Hoon Jeong
Journal:  Cancer Biol Ther       Date:  2012-12-19       Impact factor: 4.742

Review 5.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

6.  TOX4 and NOVA1 proteins are partners of the LEDGF PWWP domain and affect HIV-1 replication.

Authors:  Mehdi Morchikh; Monica Naughtin; Francesca Di Nunzio; Johan Xavier; Pierre Charneau; Yves Jacob; Marc Lavigne
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 7.  High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer.

Authors:  Aida Barreiro-Alonso; Mónica Lamas-Maceiras; Esther Rodríguez-Belmonte; Ángel Vizoso-Vázquez; María Quindós; M Esperanza Cerdán
Journal:  Oxid Med Cell Longev       Date:  2015-11-23       Impact factor: 6.543

Review 8.  Emerging roles for HMGB1 protein in immunity, inflammation, and cancer.

Authors:  Simona Martinotti; Mauro Patrone; Elia Ranzato
Journal:  Immunotargets Ther       Date:  2015-05-26

9.  HMGB4 is expressed by neuronal cells and affects the expression of genes involved in neural differentiation.

Authors:  Ari Rouhiainen; Xiang Zhao; Päivi Vanttola; Kui Qian; Evgeny Kulesskiy; Juha Kuja-Panula; Kathleen Gransalke; Mikaela Grönholm; Emmanual Unni; Marvin Meistrich; Li Tian; Petri Auvinen; Heikki Rauvala
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

10.  HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer.

Authors:  Deyuan Fu; Jing Li; Jinli Wei; Zhengquan Zhang; Yulin Luo; Haosheng Tan; Chuanli Ren
Journal:  Cell Commun Signal       Date:  2018-02-20       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.